If symptoms persist, the FAQ advises that the provider will help manage or adjust treatment
Data Availability Statement No new data were created or analyzed in this study.
The Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) trial focused on adults aged 50 years with either established or newly diagnosed type 2 diabetes and additional cardiovascular risk factors, and this trial investigated subjects with HbA1c 9.5%, receiving up to two oral glucose-lowering drugs with or without basal insulin, and a body mass index of at least 23 kg/m 2
Diarrhoea Diarrhoea is another potential side effect, as GLP-1 medications can alter the digestive process
Although DSM-5 diagnosis is defined through multiple behavioral criteria encompassing impaired control, social dysfunction, continued use despite harm, and tolerance or withdrawal, converging clinical and preclinical evidence indicates that the core pathological feature of SUDs is the progressive loss of control over intake (O'Brien, 2005)
Although some patients begin to notice accelerated weight loss within the first month, it may take up to 12 weeks of regular use to start seeing significant results